furosemide/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases all-cause mortality
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Finding“In the matched analysis, furosemide use was associated with significantly lower 28-day mortality (44.3% vs 58.6%; HR 0.58, 95% CI 0.46-0.73, p < 0.001).”
Quoted verbatim from Pre-CRRT furosemide and mortality in sepsis-associated AKI: A retrospective cohort study.. - Study
- cohort
- Duration
- 4 weeks
- Population
- Adults with sepsis-associated acute kidney injury requiring continuous renal replacement therapy (MIMIC-IV), propensity-matched; furosemide within 72 hours before CRRT versus none; 28-day horizon
Effect 0.58 hazard ratio, 95% CI 0.46 to 0.73
Pre-CRRT furosemide and mortality in sepsis-associated AKI: A retrospective cohort study.2026PMID:42008485Permalink
Keep reading
- Everything the graph holds on furosemide
- Every compound studied against All-cause mortality
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4QCRPJZT26GB3AWTWZYNVK6